课题基金 / 基金详情

Understanding the mechanism of 4-1BB costimulation

Understanding the mechanism of 4-1BB costimulation
了解4-1BB共刺激机制
批准号:
6506130
负责人:
Anthony T Vella
金额:
$32.63万
依托单位国家:
美国
项目类别:
财政年份:
2002
资助国家:
美国
项目状态:
已结题
起止时间:
2002-09-30 至 2003-09-29

项目摘要

项目成果

Anthony T Vella的其他基金

相似基金

相关文献

中文摘要
翻译
描述(由研究人员提供):有充分的文献证明,两种信号,一种来自T细胞受体,另一种来自共刺激分子,在刺激T细胞方面比单独使用一个信号更有效。有几个特征良好的T细胞共刺激信号,没有一个比CD28研究得更多。CD28结合TCR信号通路可诱导强大的T细胞活化,表现为IL-2的分泌和强大的增殖反应。我们对另一种有效的T细胞共刺激分子4-1BB的研究显示了几个有趣的相似之处,但也有深刻的区别。在活化的T细胞上结扎4-1BB可诱导类似的功能,如促进细胞因子的分泌和增殖。相反,4-1BB在静息细胞上不表达。在我们的活体模型中,最显著的区别可能是,与CD28结扎不同,4-1BB刺激可以诱导CD8T细胞长期存活。生存如何发展的机制尚不清楚,但这是这项提议的一个主要焦点。例如,T细胞是在激活诱导的细胞死亡阶段分裂并大量积累,以至于许多细胞通过稀释而避免死亡,还是因为4-1BB刺激而天生对死亡刺激具有抵抗力?这个问题得到了解决,生存的根本机制是什么的问题也得到了解决。我们将研究哪些细胞群“帮助”4-1 BB刺激的T细胞存活,并揭示在抗原刺激和共刺激后生存的要求。作为最初的线索,佐剂和佐剂诱导的细胞因子与4-1 BB刺激协同作用可以诱导大量的长期T细胞存活。实验旨在确定哪些细胞因子是关键,以及这些细胞因子是如何发挥作用的。也许最令人惊讶的是,4-1 BB拯救的CD8 T细胞表现为抑制性细胞,而不是典型的被典型的共刺激分子共刺激的典型记忆细胞。结果表明,解救细胞具有阻断CD4T细胞增殖和IL-2产生的能力。这些结果被非常详细地阐述,并最终将支持一个有趣的概念,即并不是所有的共刺激信号的功能都是一致的。
英文摘要
DESCRIPTION (provided by investigator): It is well documented that two signals, one through the T cell receptor and a second from a costimulatory molecule, are more efficient at stimulating T cells then one signal alone. There are several well-characterized T cell costimulatory signals, none of which has been studied more than CD28. CD28 ligation in conjunction with TCR signaling induces potent T cell activation as manifested by the secretion of lL-2 and robust proliferative response. Our studies of 4-1 BB another potent T cell costimulatory molecule, have shown several interesting parallels, but also profound differences. Ligation of 4-1 BB on activated T cells induces similar functions such as heightened cytokine secretion and proliferation. In contrast, however, 4-1 BB is not expressed on resting cells. Perhaps the most dramatic difference in our in vivo models is that unlike CD28 ligation, 4-1 BB stimulation induces CD8 T cell long-term survival. The mechanics of how survival develops is unknown, but is a major focus of this proposal. For example, do T cells divide throughout the activation-induced cell death phase and accumulate in massive numbers such that many of them avoid death by dilution, or are they inherently resistant to death stimuli because of 4-1BB stimulation? This issue is addressed, as is the question of what is the underlying mechanism of survival. We will examine which cell populations "help" the 4-1 BB stimulated T cells survive and uncover the requirements for survival after Ag stimulation and costimulation. As an initial clue it is clear that adjuvants and adjuvant-inducing cytokines synergize with 4-1 BB stimulation to induce huge levels of long term T cell survival. Experiments are designed to determine which cytokines are key and how the cytokines function. Perhaps what is most striking is that the 4-1 BB-rescued CD8 T cells behave as inhibitory cells rather than typical memory cells which have been costimulated by prototypical costimulatory molecules. It is shown that the rescued cells possess the ability to block CD4 T cell proliferation and lL-2 production. These results are addressed in great detail and ultimately will lend credence to the interesting notion that not all costimulatory signals function in congruence.
期刊论文(7)
专著(0)
科研奖励(0)
会议论文
DOI: 10.4049/jimmunol.181.11.7728
发表时间: 2008-12-01
期刊: Journal of immunology (Baltimore, Md. : 1950)
影响因子: --
作者: [Bandyopadhyay S, Long M, Qui HZ, Hagymasi AT, Slaiby AM, Mihalyo MA, Aguila HL, Mittler RS, Vella AT, Adler AJ]
通讯作者: Adler AJ
MiR-150 regulated adiose tissue B cells in obesity
MiR-150 regulated adiose tissue B cells in obesity
IRAK4 and Systemic Lupus Erythematosus
IRAK4 and Systemic Lupus Erythematosus
国内基金
海外基金
Epac1/2通过蛋白酶体调控中性粒细胞NETosis和Apoptosis在急性肺损伤中的作用研究
  • 批准号:
    LBY21H010001
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2020
  • 负责人:
    郑绪阳
  • 依托单位:
基于Apoptosis/Ferroptosis双重激活效应的天然产物AlbiziabiosideA的抗肿瘤作用机制研究及其结构改造
  • 批准号:
    81703335
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    20.0万元
  • 批准年份:
    2017
  • 负责人:
    卫高菲
  • 依托单位:
双肝移植后Apoptosis和pyroptosis在移植物萎缩差异中的作用和供受者免疫微环境变化研究
  • 批准号:
    81670594
  • 项目类别:
    面上项目
  • 资助金额:
    58.0万元
  • 批准年份:
    2016
  • 负责人:
    陈昊
  • 依托单位:
Serp-2 调控apoptosis和pyroptosis 对肝脏缺血再灌注损伤的保护作用研究
  • 批准号:
    81470791
  • 项目类别:
    面上项目
  • 资助金额:
    73.0万元
  • 批准年份:
    2014
  • 负责人:
    董家鸿
  • 依托单位: